This trial is active, not recruiting.

Condition malocclusion
Treatments movement enhancement technique, clear aligner
Sponsor Align Technology, Inc.
Start date February 2014
End date February 2018
Trial size 88 participants
Trial identifier NCT02087163, CSP-700007-00


The purpose of this study is to use clear aligners to measure tooth movement and length of treatment.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model single group assignment
Primary purpose treatment
Masking no masking
Movement Enhancement Technique Clear Aligner
movement enhancement technique
Conventional Orthodontic treatment
clear aligner
Orthodontic treatment with Clear Aligner

Primary Outcomes

Tooth movement change will be calculated weekly
time frame: Baseline and 6 weeks

Secondary Outcomes

Length of treatment change will be calculated as number of clear aligners used monthly
time frame: Baseline and 6 months

Eligibility Criteria

All participants from 16 years up to 46 years old.

Inclusion Criteria: - Require Orthodontic Treatment - Have a permanent dentition - No craniofacial anomaly present - No past and present signs and symptoms of periodontal disease - No significant medical history or medication that would adversely affect the development or structure of the teeth and jaws and any subsequent tooth movement - No previous orthodontic or orthopaedic relapse - No history of trauma, bruxism or parafunction - 16- 46 years old, inclusive - No skeletal jaw discrepancy - Angle Class I or Class II molar and canine relationship - Crowding of at least 4mm per arch - No osteoporosis drugs Exclusion Criteria: - Subjects who do not fulfill all inclusion criteria requirements

Additional Information

Official title The Use of Clear Aligners With Movement Enhacement Techniques
Principal investigator Chenin
Description Orthodontic tooth movement is the result of a force applied to the crown of a tooth and the biological remodeling of the gum and bony tissues.
Trial information was received from ClinicalTrials.gov and was last updated in February 2017.
Information provided to ClinicalTrials.gov by Align Technology, Inc..